Using a digital platform to improve treatment adherence in early psychosis patients
Evaluating the Effectiveness of a Digital Platform in the Engagement and Prognosis of Patients in the Early Intervention Programme in Psychosis
This study tests if a new app can help young adults with early psychosis stick to their treatment better than just standard care alone.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 128 (estimated) |
| Ages | 18 Years to 40 Years |
| Sex | All |
| Sponsor | Fundació Sant Joan de Déu Academic / other |
| Locations | 1 site (Sant Boi de Llobregat, Barcelona) |
| Trial ID | NCT06556251 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of the PIPPEP platform in enhancing treatment adherence among young adults aged 18 to 40 who are undergoing early intervention for psychosis. Participants are randomly assigned to either receive the PIPPEP app alongside standard treatment or to receive standard treatment alone. The study aims to assess not only adherence to psychosocial and pharmacological treatments but also the cost-effectiveness of the app and its impact on various clinical and functional outcomes. The trial focuses on improving patient engagement through technology to foster better mental health management.
Who should consider this trial
Good fit: Ideal candidates are young adults aged 18 to 40 who are receiving community-based treatment for early psychosis.
Not a fit: Patients without access to a mobile device or those who lack the necessary skills to use the platform may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve treatment adherence and overall outcomes for young patients experiencing early psychosis.
How similar studies have performed: Previous studies have shown that online and mobile interventions can effectively improve self-care practices and engagement in mental health treatment, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Age between 18 and 40 years * Fulfil the criteria for one of the three groups (First Psychotic Episodes, Critical Period or Ultra High Risk of Psychosis; UHR) * To undergo community-based treatment as part of one of our facility's early intervention programmes for psychosis * Have signed the informed consent form for the study. Exclusion criteria: * No mobile phone/laptop/tablet to use the platform. * Lack of skills and/or knowledge to use the platform. * Not have knowledge of the Catalan or Spanish language. * Have a diagnosed mental disability (premorbid Intelligence Quotient \<70). * Have had a medical condition that better explains the psychotic symptoms.
Where this trial is running
Sant Boi de Llobregat, Barcelona
- Parc Sanitari Sant Joan de Déu — Sant Boi de Llobregat, Barcelona, Spain (Recruiting)
Study contacts
- Study coordinator: Maria Trinidad Peláez Martínez
- Email: mtrinidad.pelaez@sjd.es
- Phone: 0034 670 971 773
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.